Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Dennis Sandell"'
Autor:
Sagar S, Bachhav, Poonam, Sheth, Dennis, Sandell, Mårten, Svensson, Sharvari, Bhagwat, Denise S, Conti, Oluwamurewa, Oguntimein, Sneha, Dhapare, Bhawana, Saluja, Lawrence, Winner, Jürgen B, Bulitta, Guenther, Hochhaus
Publikováno v:
The AAPS Journal. 24
The therapeutic benefits of metered dose inhalers (MDIs) in pulmonary disorders are mainly driven by aerosol performance, which depends on formulation variables (drug and excipients), device design, and patient interactions. The present study provide
Autor:
Christine Tabulov, Robert Price, Jürgen B. Bulitta, Xiangyin Wei, Jagdeep Shur, Elham Amini, Minori Kinjo, Dennis Sandell, Mutasim Abu-Hasan, Jie Shao, Oluwamurewa Oguntimein, Yuanyuan Jiao, Bhargava Kandala, Sau L. Lee, Renishkumar Delvadia, Günther Hochhaus, Sandra Baumstein, Brandon Seay, Cynthia Carrasco, Uta Schilling, Michael Hindle, Simon M. Berger, Lawrence H. Winner, Denise S. Conti, Stefanie K. Drescher, Mong-Jen Chen, Abhinav Kurumaddali, Bhawana Saluja
Publikováno v:
The AAPS Journal. 24
Autor:
Robert Price, Elham Amini, Jagdeep Shur, Renishkumar Delvadia, Mong-Jen Chen, Xiangyin Wei, Oluwamurewa Oguntimein, Mutasim Abu-Hasan, Jürgen B. Bulitta, Stefanie K. Drescher, Dennis Sandell, Sau L. Lee, Günther Hochhaus, Bhawana Saluja, Yuanyuan Jiao, Cynthia Carrasco, Lawrence H. Winner, Denise S. Conti, Minori Kinjo, Christine Tabulov, Michael Hindle, Jie Shao, Uta Schilling, Sandra Baumstein, Brandon Seay, Abhinav Kurumaddali, Bhargava Kandala
Publikováno v:
The AAPS Journal. 23
In the context of streamlining generic approval, this study assessed whether pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products (OIDPs). Three fluticasone propionate (FP) dry powder inhaler (DPI) formulations (A-
Autor:
Anubhav Kaviratna, Michael Hindle, Xiangyin Wei, Renishkumar Delvadia, Dennis Sandell, Peter R. Byron, Bao K. Huynh
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31:358-371
Background: In vitro-in vivo correlations (IVIVC) for lung deposition may be established by testing inhalers in vitro with realistic mouth-throat (MT) models and inhalation profiles (IP). This study was designed to compare the currently available MT
Autor:
Dennis Sandell
Publikováno v:
Advanced Drug Delivery Reviews. 176:113895
Many pharmaceutical developers of generic orally inhaled products (OIPs) are facing significant issues in passing the regulatory requirement to show pharmacokinetic (PK) bioequivalence (BE) to the originator product. The core of the issue is that no
Publikováno v:
AAPS PharmSciTech. 19:565-572
Determination of fine droplet dose with preparations for nebulization, currently deemed to be the metric most indicative of lung deposition and thus in vivo responses, involves combining two procedures following practice as described in the United St
Autor:
Juergen B Bulitta, Beth Morgan, Günther Hochhaus, Christopher Wiggenhorn, David Christopher, Svetlana Lyapustina, Abhinav Kurumaddali, Helen Strickland, Dennis Sandell, Stephen W. Stein
Publikováno v:
AAPS PharmSciTech. 20
The performances of three statistical approaches for assessing in vitro equivalence was evaluated with a set of 55 scenarios of realistic test (T) and reference (R) cascade impactor (CI) profiles (originally employed by the Product Quality Research I
Autor:
Steven C. Nichols, Dennis Sandell
Publikováno v:
Pharmaceutical Inhalation Aerosol Technology ISBN: 9780429055201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16dc8330eaf30b4ceb618ab41ebb44b3
https://doi.org/10.1201/9780429055201-27
https://doi.org/10.1201/9780429055201-27
Autor:
Reza Mohammadi, Dennis Sandell, Andrew Babiskin, Sana Hosseini, Ross Walenga, Theodore A. Schuman, Laleh Golshahi, Arun V. Kolanjiyil, Amir R. Esmaeili, Ali Alfaifi, Michele Dario Manniello, Michael Hindle
Publikováno v:
International Journal of Pharmaceutics. 593:120103
Quantifying drug delivery to the site of action using locally-acting nasal suspension sprays is a challenging but important step toward understanding bioequivalence (BE) between test and reference products. The main objective of this study was to inv
Autor:
Steven C. Nichols, Manfred Fischer, Jolyon P. Mitchell, Markus Howald, Phillip Krüger, Roy Pengilley, Dennis Sandell, Patrik U. Andersson
Publikováno v:
AAPS PharmSciTech. 17:1383-1392
Fine particle dose (FPD) is a critical quality attribute for orally inhaled products (OIPs). The abbreviated impactor measurement (AIM) concept simplifies its measurement, provided there is a validated understanding of the relationship with the full